Value of FDG-PET as a supporting biomarker for dementia with Lewy bodies at stages of early dopaminergic loss

Publication year

2020

Number of pages

1 p.

Source

Nuklearmedizin. Nuclear Medicine, 59, 2, (2020), pp. P155

ISSN

DOI

https://doi.org/10.1055/s-0040-1708403

Publication type

Article / Letter to editor

Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/220345

https://hdl.handle.net/2066/220345

Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.